Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD

Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists

(2021) Yasser Fouad et al.   JOURNAL OF HEPATOLOGY

Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population

(2021) Stefano Ciardullo et al.   LIVER INTERNATIONAL

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience

(2021) Nahum Méndez-Sánchez et al.   JOURNAL OF HEPATOLOGY

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

(2020) Sakura Yamamura et al.   LIVER INTERNATIONAL

A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients

(2020) Mohammed Eslam et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical utility of the MAFLD definition

(2020) Kenneth I. Zheng et al.   JOURNAL OF HEPATOLOGY

When a new definition overhauls perceptions of MAFLD related cirrhosis care

(2020) Kenneth I. Zheng et al.   Hepatobiliary Surgery and Nutrition

MAFLD and risk of CKD

(2020) Dan-Qin Sun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Non-alcoholic fatty liver disease: A growing public health problem in Turkey

(2019) Eda Kaya et al.   Turkish Journal of Gastroenterology

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease

(2018) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis

(2018) Samuel J. Daniels et al.   HEPATOLOGY

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

(2016) Fabio Piscaglia et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population

(2015) Sahil Mittal et al.   Clinical Gastroenterology and Hepatology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease

(2014) Maryann Maximos et al.   HEPATOLOGY

Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C

(2014) Mette J. Nielsen et al.   LIVER INTERNATIONAL

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology